A critical assessment of the methodologies to investigate the role of inhibition of apoptosis in rodent hepatocarcinogenesis

References

• Abbas AK, Kumar V, Fausto N, eds. (2005). Cellular adaptations, cell injury and cell death. In Robbins and Cotran pathologic basis of disease. 7th ed. Philadelphia (PA): Elsevier Saunders
   Google Scholar
• Adams JM, Cory S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281:1322–6
   PubMed Web of Science ®Google Scholar
• Adida C, Berrebi D, Peuchmaur M, et al. (1998). Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351:882–3
   PubMed Web of Science ®Google Scholar
• Altieri DC. (2003). Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res 5:447–52
   PubMedGoogle Scholar
• Ambrosini G, Adida C, Altieri DC. (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–21
   PubMed Web of Science ®Google Scholar
• Anagnostou VK, Lowery FJ, Zolota V, et al. (2010). High expression of Bcl-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology. BMC Cancer 10:186
   PubMed Web of Science ®Google Scholar
• Annunziata CM, Davis RE, Demchenko Y, et al. (2007). Frequent engagement of the classical and alternative Nf-KappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12:115–30
   PubMed Web of Science ®Google Scholar
• Ansari B, Coates PJ, Greenstein BD, Hall PA. (1993). In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170:1–8
   PubMed Web of Science ®Google Scholar
• Ashby J. (1992). Prediction of non-genotoxic carcinogenesis. Toxicol Lett 64–65: 605–12
   Google Scholar
• Ashby J, Purchase IF. (1992). Nongenotoxic carcinogens: an extension of the perspective provided by Perera. Environ Health Perspect 98:223–6
   PubMed Web of Science ®Google Scholar
• Bargou RC, Emmerich F, Krappmann D, et al. (1997). Constitutive nuclear factor-kappa B-rela activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100:2961–9
   PubMed Web of Science ®Google Scholar
• Bayly AC, Roberts RA, Dive C. (1994). Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J Cell Biol 125:197–203
   PubMed Web of Science ®Google Scholar
• Bishnoi M, Chopra K, Kulkarni SK. (2008). Activation of striatal inflammatory mediators and caspase-3 is central to haloperidol-induced orofacial dyskinesia. Eur J Pharmacol 590:241–5
   PubMed Web of Science ®Google Scholar
• Boverhof DR, Chamberlain MP, Elcombe CR, et al. (2011). Transgenic animal models in toxicology: historical perspectives and future outlook. Toxicol Sci 121:207–33
   PubMed Web of Science ®Google Scholar
• Budinsky RA, Schrenk D, Simon T, et al. (2014). Mode of action and dose-response framework analysis for receptor-mediated toxicity: the aryl hydrocarbon receptor as a case study. Crit Rev Toxicol 44:83–119
   PubMed Web of Science ®Google Scholar
• Carter BZ, Milella M, Tsao T, et al. (2003). Regulation and targeting of antiapoptotic xiap in acute myeloid leukemia. Leukemia 17:2081–9
   PubMed Web of Science ®Google Scholar
• Chiu HH, Yong TM, Wang J, et al. (2010). Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancer. Cancer Lett 292:176–85
   PubMed Web of Science ®Google Scholar
• Choi J, Hwang YK, Choi YJ, et al. (2007). Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancer. J Korean Med Sci 22:S17–23
   PubMed Web of Science ®Google Scholar
• Chopra M, Dharmarajan AM, Meiss G, Schrenk D. (2009). Inhibition of UV-C light-induced apoptosis in liver cells by 2,3,7,8-tetrachlorodibenzo-P-dioxin. Toxicol Sci 111:49–63
   PubMed Web of Science ®Google Scholar
• Chopra M, Gahrs M, Haben M, et al. (2010). Inhibition of apoptosis by 2,3,7,8-tetrachlorodibenzo-P-dioxin depends on protein biosynthesis. Cell Biol Toxicol 26:391–401
   PubMed Web of Science ®Google Scholar
• Chopra M, Schrenk D. (2011). Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis-persistent pollutants affect programmed cell death. Crit Rev Toxicol 41:292–320
   PubMed Web of Science ®Google Scholar
• Cohen SM, Arnold LL. (2011). Chemical carcinogenesis. Toxicol Sci 120:S76–92
   PubMed Web of Science ®Google Scholar
• Colnaghi R, Connell CM, Barrett RM, Wheatley SP. (2006). Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem 281:33450–6
   PubMed Web of Science ®Google Scholar
• Combes RD. (2000). The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens. Toxicol In Vitro 14:387–99
   PubMed Web of Science ®Google Scholar
• Combes RD, Judson P. (1995). The use of artificial intelligence systems for predicting toxicity. Pesticide Sci 45:179–94
   Google Scholar
• Corton JC, Cunningham ML, Hummer BT, et al. (2014). Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (Pparalpha) as a case study. Crit Rev Toxicol 44:1–49
   PubMed Web of Science ®Google Scholar
• Cunningham AR, Rosenkranz HS, Zhang YP, Klopman G. (1998). Identification of ‘genotoxic' and ‘non-genotoxic' alerts for cancer in mice: the carcinogenic potency database. Mutat Res 398:1–17
   PubMed Web of Science ®Google Scholar
• Dawson SJ, Makretsov N, Blows FM, et al. (2010). Bcl2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br J Cancer 103:668–75
   PubMed Web of Science ®Google Scholar
• Deveraux QL, Reed JC. (1999). Iap family proteins – suppressors of apoptosis. Genes Dev 13:239–52
   PubMed Web of Science ®Google Scholar
• Deveraux QL, Roy N, Stennicke HR, et al. (1998). Iaps block apoptotic events induced by caspase-8 and cytochrome C by direct inhibition of distinct caspases. Embo J 17:2215–23
   PubMed Web of Science ®Google Scholar
• Devi GR. (2004). Xiap as target for therapeutic apoptosis in prostate cancer. Drug News Perspect 17:127–34
   PubMed Web of Science ®Google Scholar
• Dierlamm J, Baens M, Wlodarska I, et al. (1999). The apoptosis inhibitor gene Api2 and A novel 18q gene, Mlt, are recurrently rearranged in the T(11;18)(Q21;Q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93:3601–9
   PubMed Web of Science ®Google Scholar
• Elcombe CR, Peffer RC, Wolf DC, et al. (2014). Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (Car) activator. Crit Rev Toxicol 44:64–82
   PubMed Web of Science ®Google Scholar
• Elmore S. (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495–516
   PubMed Web of Science ®Google Scholar
• Emanuel PO, Phelps RG, Mudgil A, et al. (2008). Immunohistochemical detection of Xiap in melanoma. J Cutan Pathol 35:292–7
   PubMed Web of Science ®Google Scholar
• Esposito I, Kleeff J, Abiatari I, et al. (2007). Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer. J Clin Pathol 60:885–95
   PubMed Web of Science ®Google Scholar
• Fields AC, Cotsonis G, Sexton D, et al. (2004). Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome. Mod Pathol 17:1378–85
   PubMed Web of Science ®Google Scholar
• Fukuda S, Pelus LM. (2006). Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 5:1087–98
   PubMed Web of Science ®Google Scholar
• Gerbracht U, Bursch W, Kraus P, et al. (1990). Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver. Carcinogenesis 11:617–24
   PubMed Web of Science ®Google Scholar
• Gerl R, Vaux DL. (2005). Apoptosis in the development and treatment of cancer. Carcinogenesis 26:263–70
   PubMed Web of Science ®Google Scholar
• Gill C, Dowling C, O'neill AJ, Watson RW. (2009). Effects of Ciap-1, Ciap-2 and Xiap triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation. Mol Cancer 8:39
   PubMed Web of Science ®Google Scholar
• Gilmore TD, Koedood M, Piffat KA, White DW. (1996). Rel/Nf-Kappab/Ikappab proteins and cancer. Oncogene 13:1367–78
   PubMed Web of Science ®Google Scholar
• Gong J, Chen N, Zhou Q, et al. (2005). Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas. J Clin Pathol 58:1081–5
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Peters JM, Cattley RC. (1998). Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha. J Natl Cancer Inst 90:1702–9
   PubMed Web of Science ®Google Scholar
• Gumienny TL, Lambie E, Hartwieg E, et al. (1999). Genetic control of programmed cell death in the Caenorhabditis elegans hermaphrodite germline. Development 126:1011–22
   PubMed Web of Science ®Google Scholar
• Hasmall SC, West DA, Olsen K, Roberts RA. (2000). Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro. Carcinogenesis 21:2159–65
   PubMed Web of Science ®Google Scholar
• Hengartner MO. (2000). The biochemistry of apoptosis. Nature 407:770–6
   PubMed Web of Science ®Google Scholar
• Holcik M, Gibson H, Korneluk RG. (2001). Xiap: apoptotic brake and promising therapeutic target. Apoptosis 6:253–61
   PubMed Web of Science ®Google Scholar
• Hu S, Snipas SJ, Vincenz C, et al. (1998). Caspase-14 is a novel developmentally regulated protease. J Biol Chem 273:29648–53
   PubMed Web of Science ®Google Scholar
• Intrasuksri U, Feller DR. (1991). Comparison of the effects of selected monocarboxylic, dicarboxylic and perfluorinated fatty acids on peroxisome proliferation in primary cultured rat hepatocytes. Biochem Pharmacol 42:184–8
   PubMed Web of Science ®Google Scholar
• James NH, Roberts RA. (1996). Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. Carcinogenesis 17:1623–32
   PubMed Web of Science ®Google Scholar
• James NH, Soames AR, Roberts RA. (1998). Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB). Arch Toxicol 72:784–90
   PubMed Web of Science ®Google Scholar
• Jeremias I, Kupatt C, Baumann B, et al. (1998). Inhibition of nuclear factor KappaB activation attenuates apoptosis resistance in lymphoid cells. Blood 91:4624–31
   PubMed Web of Science ®Google Scholar
• Kang BH, Ko E, Kwon OK, Choi KY. (2002). The structure of procaspase 6 is similar to that of active mature caspase 6. Biochem J 364:629–34
   PubMed Web of Science ®Google Scholar
• Kawasaki H, Altieri DC, Lu CD, et al. (1998). Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071–4
   PubMed Web of Science ®Google Scholar
• Kawasaki H, Toyoda M, Shinohara H, et al. (2001). Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91:2026–32
   PubMed Web of Science ®Google Scholar
• Keats JJ, Fonseca R, Chesi M, et al. (2007). Promiscuous mutations activate the noncanonical Nf-kappaB pathway in multiple myeloma. Cancer Cell 12:131–44
   PubMed Web of Science ®Google Scholar
• Kerr JF, Wyllie AH, Currie AR. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–57
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Kamendulis LM, Xu Y. (2000). Epigenetic mechanisms of chemical carcinogenesis. Hum Exp Toxicol 19:543–55
   PubMed Web of Science ®Google Scholar
• Koenig U, Eckhart L, Tschachler E. (2001). Evidence that caspase-13 is not a human but a bovine gene. Biochem Biophys Res Commun 285:1150–4
   PubMed Web of Science ®Google Scholar
• Kokel D, Li Y, Qin J, Xue D. (2006). The nongenotoxic carcinogens naphthalene and para-dichlorobenzene suppress apoptosis in Caenorhabditis elegans. Nat Chem Biol 2:338–45
   PubMed Web of Science ®Google Scholar
• Kokel D, Xue D. (2006). A class of benzenoid chemicals suppresses apoptosis in C. elegans. Chembiochem 7:2010–15
   PubMed Web of Science ®Google Scholar
• Kolaja KL, Stevenson DE, Walborg EF, Jr Klaunig JE. (1996). Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6c3f1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis 17:947–54
   PubMed Web of Science ®Google Scholar
• Krajewska M, Fenoglio-Preiser CM, Krajewski S, et al. (1996a). Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am J Pathol 149:1449–57
   PubMed Web of Science ®Google Scholar
• Krajewska M, Krajewski S, Epstein JI, et al. (1996b). Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in prostate cancers. Am J Pathol 148:1567–76
   PubMed Web of Science ®Google Scholar
• Krajewski S, Blomqvist C, Franssila K, et al. (1995a). Reduced expression of proapoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55:4471–8
   PubMed Web of Science ®Google Scholar
• Krajewski S, Mai JK, Krajewska M, et al. (1995b). Upregulation of Bax protein levels in neurons following cerebral ischemia. J Neurosci 15:6364–76
   PubMed Web of Science ®Google Scholar
• Lacasse EC, Baird S, Korneluk RG, Mackenzie AE. (1998). The inhibitors of apoptosis (Iaps) and their emerging role in cancer. Oncogene 17:3247–59
   PubMed Web of Science ®Google Scholar
• Lima RT, Martins LM, Guimaraes JE, et al. (2004). Specific downregulation of Bcl-2 and Xiap By Rnai enhances the effects of chemotherapeutic agents in Mcf-7 human breast cancer cells. Cancer Gene Ther 11:309–16
   PubMed Web of Science ®Google Scholar
• Liu Z, Kelly R, Fang H, et al. (2011). Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships. Chem Res Toxicol 24:1062–70
   PubMed Web of Science ®Google Scholar
• Lu CD, Altieri DC, Tanigawa N. (1998). Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and P53 accumulation in gastric carcinomas. Cancer Res 58:1808–12
   PubMed Web of Science ®Google Scholar
• Lu N, Yu X, He X, Zhou Z. (2009). Detecting apoptotic cells and monitoring their clearance in the nematode Caenorhabditis elegans. Methods Mol Biol 559:357–70
   PubMedGoogle Scholar
• Luque I, Gelinas C. (1997). Rel/Nf-kappa B and I kappa B factors in oncogenesis. Semin Cancer Biol 8:103–11
   PubMed Web of Science ®Google Scholar
• Majno G, Joris I. (1995). Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3–15
   PubMed Web of Science ®Google Scholar
• Mangahas PM, Yu X, Miller KG, Zhou Z. (2008). The small Gtpase Rab2 functions in the removal of apoptotic cells in Caenorhabditis elegans. J Cell Biol 180:357–73
   PubMed Web of Science ®Google Scholar
• Mckinney JD, Richard A, Waller C, et al. (2000). The practice of structure activity relationships (SAR) in toxicology. Toxicol Sci 56:8–17
   PubMed Web of Science ®Google Scholar
• Melnick RL, Kohn MC, Portier CJ. (1996). Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis. Environ Health Perspect 104:123–34
   PubMed Web of Science ®Google Scholar
• Migheli A, Cavalla P, Piva R, et al. (1994). Bcl-2 protein expression in aged brain and neurodegenerative diseases. Neuroreport 5:1906–8
   PubMed Web of Science ®Google Scholar
• Miura K, Karasawa H, Sasaki I. (2009). Ciap2 as a therapeutic target in colorectal cancer and other malignancies. Expert Opin Ther Targets 13:1333–45
   PubMed Web of Science ®Google Scholar
• Mizutani Y, Nakanishi H, Li YN, et al. (2007). Overexpression of Xiap expression in renal cell carcinoma predicts a worse prognosis. Int J Oncol 30:919–25
   PubMed Web of Science ®Google Scholar
• Morinaga S, Nakamura Y, Ishiwa N, et al. (2004). Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. Oncol Rep 12:1189–94
   PubMed Web of Science ®Google Scholar
• Mundle SD, Raza A. (1995). The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis. Lab Invest 72:611–13
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Zhu H, Morishima N, et al. (2000). Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403:98–103
   PubMed Web of Science ®Google Scholar
• Nakshatri H, Bhat-Nakshatri P, Martin DA, et al. (1997). Constitutive activation of Nf-KappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629–39
   PubMed Web of Science ®Google Scholar
• O'Brien MA, Kirby R. (2008). Apoptosis: a review of pro-apoptotic and anti-apoptotic pathways and dysregulation in disease. J Vet Emerg Crit Care 18:572–85
   Web of Science ®Google Scholar
• Oberhammer FA, Pavelka M, Sharma S, et al. (1992). Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci U S A 89:5408–12
   PubMed Web of Science ®Google Scholar
• Ooi SL, Priess JR, Henikoff S. (2006). Histone H3.3 variant dynamics in the germline of Caenorhabditis elegans. Plos Genet 2:E97
   PubMedGoogle Scholar
• Paajarvi G, Viluksela M, Pohjanvirta R, et al. (2005). TCDD activates Mdm2 and attenuates the P53 response to DNA damaging agents. Carcinogenesis 26:201–8
   PubMed Web of Science ®Google Scholar
• Perl M, Chung CS, Ayala A. (2005). Apoptosis. Crit Care Med 33:S526–9
   PubMed Web of Science ®Google Scholar
• Rakitsky VN, Koblyakov VA, Turusov VS. (2000). Nongenotoxic (epigenetic) carcinogens: pesticides as an example. A critical review. Teratog Carcinog Mutagen 20:229–40
   PubMedGoogle Scholar
• Sanders S, Thorgeirsson SS. (2000). Promotion of hepatocarcinogenesis by phenobarbital in C-Myc/Tgf-Alpha transgenic mice. Mol Carcinog 28:168–73
   PubMed Web of Science ®Google Scholar
• Schimmer AD. (2004). Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 64:7183–90
   PubMed Web of Science ®Google Scholar
• Schulte-Hermann R. (1987a). Biochemical events in nitrosamine-induced hepatocarcinogenesis: relevance of animal data to human carcinogenesis. IARC Sci Publ 84:17–19
   PubMedGoogle Scholar
• Schulte-Hermann R. (1987b). Initiation and promotion in hepatocarcinogenesis. Arch Toxicol 60:179–81
   PubMed Web of Science ®Google Scholar
• Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W. (1990). DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 50:5127–35
   PubMed Web of Science ®Google Scholar
• Shaw TJ, Lacasse EC, Durkin JP, Vanderhyden BC. (2008). Downregulation of Xiap expression in ovarian cancer cells induces cell death in vitro and in vivo. Int J Cancer 122:1430–4
   PubMed Web of Science ®Google Scholar
• Shi Y. (2002). A conserved tetrapeptide motif: potentiating apoptosis through IAP-binding. Cell Death Differ 9:93–5
   PubMed Web of Science ®Google Scholar
• Silke J, Hawkins CJ, Ekert PG, et al. (2002). The anti-apoptotic activity of Xiap is retained upon mutation of both the caspase 3- and caspase 9-interacting sites. J Cell Biol 157:115–24
   PubMed Web of Science ®Google Scholar
• Silva Lima B, Van Der Laan JW. (2000). Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard. Regul Toxicol Pharmacol 32:135–43
   PubMed Web of Science ®Google Scholar
• Sonich-Mullin C, Fielder R, Wiltse J, et al. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol 34:146–52
   PubMed Web of Science ®Google Scholar
• Stehlik C, De Martin R, Kumabashiri I, et al. (1998). Nuclear factor (Nf)-kappaB-regulated X-chromosome-linked Iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med 188:211–16
   PubMed Web of Science ®Google Scholar
• Stinchcombe S, Buchmann A, Bock KW, Schwarz M. (1995). Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-P-dioxin-mediated tumour promotion in rat liver. Carcinogenesis 16:1271–5
   PubMed Web of Science ®Google Scholar
• Sulston JE, Horvitz HR. (1977). Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol 56:110–56
   PubMed Web of Science ®Google Scholar
• Sulston JE, Schierenberg E, White JG, Thomson JN. (1983). The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol 100:64–119
   PubMed Web of Science ®Google Scholar
• Swana HS, Grossman D, Anthony JN, et al. (1999). Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341:452–3
   PubMed Web of Science ®Google Scholar
• Takai N, Miyazaki T, Nishida M, et al. (2002a). Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma. Int J Mol Med 10:211–16
   PubMed Web of Science ®Google Scholar
• Takai N, Miyazaki T, Nishida M, et al. (2002b). Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett 184:105–16
   PubMed Web of Science ®Google Scholar
• Taylor RC, Cullen SP, Martin SJ. (2008). Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9:231–41
   PubMed Web of Science ®Google Scholar
• Thornberry NA. (1998). Caspases: key mediators of apoptosis. Chem Biol 5:R97–103
   PubMed Web of Science ®Google Scholar
• Trump BF, Berezesky IK, Chang SH, Phelps PC. (1997). The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol Pathol 25:82–8
   PubMed Web of Science ®Google Scholar
• Vaux DL, Cory S, Adams JM. (1988). Bcl-2 gene promotes haemopoietic cell survival and cooperates with C-Myc to immortalize pre-B cells. Nature 335:440–2
   PubMed Web of Science ®Google Scholar
• Vaux DL, Silke J. (2005). IAPS, rings and ubiquitylation. Nat Rev Mol Cell Biol 6:287–97
   PubMed Web of Science ®Google Scholar
• Virkajarvi N, Paakko P, Soini Y. (1998). Apoptotic index and apoptosis influencing proteins Bcl-2, Mcl-1, Bax and caspases 3, 6 and 8 in pancreatic carcinoma. Histopathology 33:432–9
   PubMed Web of Science ®Google Scholar
• Vucic D, Stennicke HR, Pisabarro MT, et al. (2000). Ml-Iap, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 10:1359–66
   PubMed Web of Science ®Google Scholar
• Wang MY, Chen PS, Prakash E, et al. (2009). Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-Xl and Ciap1. Cancer Res 69:3482–91
   Google Scholar
• Wang S, Bai L, Lu J, et al. (2012). Targeting inhibitors of apoptosis proteins (IAPS) for new breast cancer therapeutics. J Mammary Gland Biol Neoplasia 17:217–28
   PubMed Web of Science ®Google Scholar
• Watanabe M, Hitomi M, Van Der Wee K, et al. (2002). The pros and cons of apoptosis assays for use in the study of cells, tissues, and organs. Microsc Microanal 8:375–91
   PubMed Web of Science ®Google Scholar
• Wei Y, Fan T, Yu M. (2008). Inhibitor of apoptosis proteins and apoptosis. Acta Biochim Biophys Sin (Shanghai) 40:278–88
   PubMed Web of Science ®Google Scholar
• Weisburger JH, Williams GM. (1981). Carcinogen testing: current problems and new approaches. Science 214:401–7
   PubMed Web of Science ®Google Scholar
• Worner W, Schrenk D. (1996). Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1. Cancer Res 56:1272–8
   PubMed Web of Science ®Google Scholar
• Yamasaki H. (1995). Non-genotoxic mechanisms of carcinogenesis: studies of cell transformation and gap junctional intercellular communication. Toxicol Lett 77:55–61
   PubMed Web of Science ®Google Scholar
• Yu X, Odera S, Chuang CH, et al. (2006). C. elegans dynamin mediates the signaling of phagocytic receptor ced-1 for the engulfment and degradation of apoptotic cells. Dev Cell 10:743–57
   PubMed Web of Science ®Google Scholar
• Zaffaroni N, Pennati M, Colella G, et al. (2002). Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol Life Sci 59:1406–12
   PubMed Web of Science ®Google Scholar
• Zhang S, Ding F, Luo A, et al. (2007). Xiap is highly expressed in esophageal cancer and its downregulation by RNAi sensitizes esophageal carcinoma cell lines to chemotherapeutics. Cancer Biol Ther 6:973–80
   PubMedGoogle Scholar
• Zhou Z, Hartwieg E, Horvitz HR. (2001). Ced-1 is a transmembrane receptor that mediates cell corpse engulfment in C. elegans. Cell 104:43–56
   PubMed Web of Science ®Google Scholar